{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:20:06Z","timestamp":1791958806317,"version":"4.3.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jgar.2018.09.010","type":"journal-article","created":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T20:20:45Z","timestamp":1537906845000},"page":"108-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["In vitro susceptibility of chromoblastomycosis agents to antifungal drugs: A systematic review"],"prefix":"10.1016","volume":"16","author":[{"given":"Alessandra Helena","family":"da Silva Hellwig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiane","family":"Heidrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis Adriel","family":"Zanette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L\u00facia","family":"Scroferneker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2018.09.010_bib0005","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3109\/13693780903471073","article-title":"Rhinocladiella aquaspersa, proven agent of verrucous skin infection and a novel type of chromoblastomycosis","volume":"48","author":"Badali","year":"2010","journal-title":"Med Mycol"},{"key":"10.1016\/j.jgar.2018.09.010_bib0010","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11046-013-9634-3","article-title":"Chromoblastomycosis due to Fonsecaea pedrosoi and F. monophora in Cuba","volume":"175","author":"Badali","year":"2013","journal-title":"Mycopathologia"},{"key":"10.1016\/j.jgar.2018.09.010_bib0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11046-013-9660-1","article-title":"A case of relapsed chromoblastomycosis due to Fonsecaea monophora: antifungal susceptibility and phylogenetic analysis","volume":"176","author":"Daboit","year":"2013","journal-title":"Mycopathologia"},{"key":"10.1016\/j.jgar.2018.09.010_bib0020","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1128\/AAC.02114-12","article-title":"In vitro antifungal susceptibility of Cladophialophora carrionii, agent of human chromoblastomycosis","volume":"57","author":"Deng","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.09.010_bib0025","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.mmcr.2013.08.001","article-title":"Chromoblastomycosis caused by Rhinocladiella aquaspersa","volume":"2","author":"Gonz\u00e1lez","year":"2013","journal-title":"Med Mycol Case Rep"},{"key":"10.1016\/j.jgar.2018.09.010_bib0030","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3109\/13693786.2012.695457","article-title":"Molecular diversity of Cladophialophora carrionii in patients with chromoblastomycosis in Venezuela","volume":"51","author":"Gonz\u00e1lez","year":"2013","journal-title":"Med Mycol"},{"key":"10.1016\/j.jgar.2018.09.010_bib0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.mmcr.2017.04.002","article-title":"Chromoblastomycosis caused by Rhinocladiella similis: case report","volume":"16","author":"Heidrich","year":"2017","journal-title":"Med Mycol Case Rep"},{"key":"10.1016\/j.jgar.2018.09.010_bib0040","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11046-014-9828-3","article-title":"Photodynamic therapy combined with terbinafine against chromoblastomycosis and the effect of PDT on Fonsecaea monophora in vitro","volume":"179","author":"Hu","year":"2015","journal-title":"Mycopathologia"},{"key":"10.1016\/j.jgar.2018.09.010_bib0045","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/myc.12308","article-title":"Phenotypic and molecular identification of Fonsecaea pedrosoi strains isolated from chromoblastomycosis patients in Mexico and Venezuela","volume":"58","author":"Carolina Rojas","year":"2015","journal-title":"Mycoses"},{"key":"10.1016\/j.jgar.2018.09.010_bib0050","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1439-0507.2008.01547.x","article-title":"Successful treatment for chromoblastomycosis caused by Fonsecaea monophora: a report of three cases in Guangdong, China","volume":"52","author":"Zhang","year":"2008","journal-title":"Mycoses"},{"key":"10.1016\/j.jgar.2018.09.010_bib0055","first-page":"451","article-title":"Synergistic effects of terbinafine and itraconazole on clinical isolates of Fonsecaea monophora","volume":"19","author":"Zhang","year":"2009","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jgar.2018.09.010_bib0060","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3109\/13693786.2012.655258","article-title":"A refractory case of chromoblastomycosis due to Fonsecaea monophora with improvement by photodynamic therapy","volume":"50","author":"Yang","year":"2012","journal-title":"Med Mycol"},{"key":"10.1016\/j.jgar.2018.09.010_bib0065","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1067\/mjd.2001.112220","article-title":"Chromoblastomycosis: a review of 100 cases in the state of Rio Grande do Sul, Brazil","volume":"44","author":"Minotto","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jgar.2018.09.010_bib0070","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11046-015-9887-0","article-title":"Cutaneous chromoblastomycosis caused by Veronaea botryosa in a patient with pemphigus vulgaris and review of published reports","volume":"180","author":"Zhu","year":"2015","journal-title":"Mycopathologia"},{"key":"10.1016\/j.jgar.2018.09.010_bib0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005102","article-title":"Molecular epidemiology of agents of human chromoblastomycosis in Brazil with the description of two novel species","volume":"10","author":"Gomes","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jgar.2018.09.010_bib0080","series-title":"Medical mycology: the pathogenic fungi and the pathogenic actinomycetes","author":"Rippon","year":"1982"},{"key":"10.1016\/j.jgar.2018.09.010_bib0085","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1128\/CMR.00032-16","article-title":"Chromoblastomycosis","volume":"30","author":"Queiroz-Telles","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jgar.2018.09.010_bib0090","series-title":"Report of the Tenth Meeting of the WHO Strategic and Technical Advisory Group for Neglected Tropical Diseases","author":"World Health Organization (WHO)","year":"2017"},{"key":"10.1016\/j.jgar.2018.09.010_bib0095","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/13693780802538001","article-title":"Chromoblastomycosis an overview of clinical manifestations, diagnosis and treatment","volume":"47","author":"Queiroz-Telles","year":"2009","journal-title":"Med Mycol"},{"key":"10.1016\/j.jgar.2018.09.010_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1439-0507.2001.00613.x","article-title":"Chromoblastomycosis clinical and mycologic experience of 51 cases","volume":"44","author":"Bonifaz","year":"2001","journal-title":"Mycoses"},{"key":"10.1016\/j.jgar.2018.09.010_bib0105","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s11046-013-9648-x","article-title":"Challenges in the therapy of chromoblastomycosis","volume":"175","author":"Queiroz-Telles","year":"2013","journal-title":"Mycopathologia"},{"key":"10.1016\/j.jgar.2018.09.010_bib0110","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1365-4362.1992.tb04252.x","article-title":"Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi","volume":"31","author":"Queiroz-Telles","year":"1992","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jgar.2018.09.010_bib0115","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1749-6632.1988.tb40448.x","article-title":"Treatment of chromoblastomycosis with itraconazole","volume":"544","author":"Restrepo","year":"1988","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jgar.2018.09.010_bib0120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1439-0507.2000.00548.x","article-title":"Case report. A case of chromoblastomycosis effectively treated with terbinafine. Characteristics of chromoblastomycosis in the Kitasato region, Japan","volume":"43","author":"Tanuma","year":"2000","journal-title":"Mycoses"},{"key":"10.1016\/j.jgar.2018.09.010_bib0125","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2133.1996.tb15658.x","article-title":"Treatment of chromomycosis with terbinafine: preliminary results of an open pilot study","volume":"134","author":"Esterre","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jgar.2018.09.010_bib0130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/09546630410024538","article-title":"Treatment of chromoblastomycosis with terbinafine: experience with four cases","volume":"16","author":"Bonifaz","year":"2005","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jgar.2018.09.010_bib0135","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1186\/s12913-014-0579-0","article-title":"PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews","volume":"14","author":"Methley","year":"2014","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jgar.2018.09.010_bib0140","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1128\/CMR.00019-10","article-title":"Melanized fungi in human disease","volume":"23","author":"Revankar","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jgar.2018.09.010_bib0145","series-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard\u2014second edition","author":"Clinical and Laboratory Standards Institute","year":"2008"},{"key":"10.1016\/j.jgar.2018.09.010_bib0150","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ijantimicag.2010.06.003","article-title":"In vitro activity of isavuconazole against 140 reference fungal strains and 165 clinically isolated yeasts from Japan","volume":"36","author":"Yamazaki","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2018.09.010_bib0155","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1128\/AAC.01015-10","article-title":"In vitro evaluation of the type of interaction obtained by the combination of terbinafine and itraconazole, voriconazole or amphotericin B against dematiaceous molds","volume":"55","author":"Biancalana","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.09.010_bib0160","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1439-0507.2009.01704.x","article-title":"Antifungal activity of Pterocaulon alopecuroides (Asteraceae) against chromoblastomycosis agents","volume":"53","author":"Daboit","year":"2009","journal-title":"Mycoses"},{"key":"10.1016\/j.jgar.2018.09.010_bib0165","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1128\/JCM.02459-16","article-title":"Rapid identification of clinically relevant members of the genus Exophiala by matrix-assisted laser desorption ionization\u2013time of flight mass spectrometry and description of two novel species, Exophiala campbellii and Exophiala lavatrina","volume":"55","author":"Borman","year":"2017","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2018.09.010_bib0170","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1439-0507.2000.00585.x","article-title":"In vitro susceptibilities of 11 clinical isolates of Exophiala species to six antifungal drugs","volume":"43","author":"Meletiadis","year":"2000","journal-title":"Mycoses"},{"key":"10.1016\/j.jgar.2018.09.010_bib0175","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1590\/S0004-27492005000200023","article-title":"Clinical treatment of corneal infection due to Fonsecaea pedrosoi\u2014case report","volume":"68","author":"H\u00f6fling-Lima","year":"2005","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.jgar.2018.09.010_bib0180","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/13693780802566333","article-title":"In vitro activity of antifungal drugs against Cladophialophora species associated with human chromoblastomycosis","volume":"47","author":"Vitale","year":"2009","journal-title":"Med Mycol"},{"key":"10.1016\/j.jgar.2018.09.010_bib0185","doi-asserted-by":"crossref","first-page":"5609","DOI":"10.1128\/AAC.02875-14","article-title":"In vitro activities of nine antifungal drugs and their combinations against Phialophora verrucosa","volume":"58","author":"Li","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.09.010_bib0190","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s11046-012-9597-9","article-title":"In vitro susceptibility of environmental isolates of Exophiala dermatitidis to five antifungal drugs","volume":"175","author":"Duarte","year":"2013","journal-title":"Mycopathologia"},{"key":"10.1016\/j.jgar.2018.09.010_bib0195","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/mmy.40.6.545.556","article-title":"Molecular diversity, new species and antifungal susceptibilities in the Exophiala spinifera clade","volume":"40","author":"Vitale","year":"2002","journal-title":"Med Mycol"},{"key":"10.1016\/j.jgar.2018.09.010_bib0200","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/13693780802163438","article-title":"In vitro interaction of terbinafine with itraconazole and amphotericin B against fungi causing chromoblastomycosis in China","volume":"46","author":"Yu","year":"2008","journal-title":"Med Mycol"},{"key":"10.1016\/j.jgar.2018.09.010_bib0205","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/myc.12111","article-title":"In vitro susceptibility of chromoblastomycosis agents to five antifungal drugs and to the combination of terbinafine and amphotericin B","volume":"57","author":"Daboit","year":"2013","journal-title":"Mycoses"},{"key":"10.1016\/j.jgar.2018.09.010_bib0210","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3109\/13693786.2011.583285","article-title":"Microdilution in vitro antifungal susceptibility of Exophiala dermatitidis, a systemic opportunist","volume":"49","author":"Badali","year":"2011","journal-title":"Med Mycol"},{"key":"10.1016\/j.jgar.2018.09.010_bib0215","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/13693780802512451","article-title":"Antifungal susceptibility testing of Exophiala spp.: a head-to-head comparison of amphotericin B, itraconazole, posaconazole and voriconazole","volume":"47","author":"Fothergill","year":"2009","journal-title":"Med Mycol"},{"key":"10.1016\/j.jgar.2018.09.010_bib0220","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.mycmed.2017.01.007","article-title":"Consistent high prevalence of Exophiala dermatitidis, a neurotropic opportunist, on railway sleepers","volume":"27","author":"Yazdanparast","year":"2017","journal-title":"J Mycol Med"},{"key":"10.1016\/j.jgar.2018.09.010_bib0225","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3389\/fmicb.2016.00617","article-title":"Evaluation of the effects of photodynamic therapy alone and combined with standard antifungal therapy on planktonic cells and biofilms of Fusarium spp. and Exophiala spp","volume":"7","author":"Gao","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2018.09.010_bib0230","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3389\/fmicb.2016.01658","article-title":"INK128 exhibits synergy with azoles against Exophiala spp. and Fusarium spp","volume":"7","author":"Gao","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2018.09.010_bib0235","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11046-014-9832-7","article-title":"1,10-Phenanthroline inhibits the metallopeptidase secreted by Phialophora verrucosa and modulates its growth, morphology and differentiation","volume":"179","author":"Granato","year":"2015","journal-title":"Mycopathologia"},{"key":"10.1016\/j.jgar.2018.09.010_bib0240","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/13693780500088416","article-title":"In vitro activities of new and established triazoles against opportunistic filamentous and dimorphic fungi","volume":"43","author":"Gonz\u00e1lez","year":"2005","journal-title":"Med Mycol"},{"key":"10.1016\/j.jgar.2018.09.010_bib0245","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/jac\/dkg218","article-title":"In vitro activity of amphotericin B and itraconazole in combination with flucytosine, sulfadiazine and quinolones against Exophiala spinifera","volume":"51","author":"Vitale","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2018.09.010_bib0250","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/13693780310001600822","article-title":"In vitro activity of amphotericin B, itraconazole, terbinafine and 5-fluocytosine against Exophiala spinifera and evaluation of post-antifungal effects","volume":"41","author":"Vitale","year":"2003","journal-title":"Med Mycol"},{"key":"10.1016\/j.jgar.2018.09.010_bib0255","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1128\/AAC.48.5.1912-1915.2004","article-title":"In vitro activity of anidulafungin against selected clinically important mold isolates","volume":"48","author":"Odabasi","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.09.010_bib0260","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ijantimicag.2008.05.015","article-title":"In vitro interactions of itraconazole and micafungin against clinically important filamentous fungi","volume":"32","author":"Ru\u00edz-Cendoya","year":"2008","journal-title":"Int J Antimicrob Agents"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716518301838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716518301838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T22:47:33Z","timestamp":1553640453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716518301838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":52,"alternative-id":["S2213716518301838"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2018.09.010","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro susceptibility of chromoblastomycosis agents to antifungal drugs: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2018.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}